Lv511
1380 积分 2024-09-05 加入
Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers
1天前
已完结
Mantle Cell Lymphoma: Optimal Treatment With Bruton Tyrosine Kinase–Targeted Approaches
1天前
已完结
Treatment of Relapsed/Refractory MCL
13天前
已完结
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation
13天前
已完结
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
14天前
已完结
Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta‐Analysis
18天前
已完结
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
18天前
已完结
Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
19天前
已完结
Idiopathic Multicentric Castleman’s Disease Presenting with Chorioretinal Undulation: A Case Report
25天前
已完结
Striking effectiveness of siltuximab-based treatment in refractory idiopathic multicentric Castleman disease resembling IgG4-related disease
26天前
已完结
皖公网安备34019202002308
